XML 51 R74.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Accumulated Other Comprehensive Income (Loss) and Shareholders' Equity (Narrative) (Details)
1 Months Ended 12 Months Ended
Aug. 31, 2019
USD ($)
Dec. 28, 2019
USD ($)
hour
shares
Dec. 29, 2018
USD ($)
Mar. 31, 2016
USD ($)
May 31, 2007
shares
Jan. 01, 2007
shares
Schedule of Shareholders' Equity [Line Items]            
Derivative asset     $ 300,000      
Accumulated other comprehensive income (loss)   $ (8,073,000) $ (3,599,000)      
Term of employment agreement   2 years        
Certain officers            
Schedule of Shareholders' Equity [Line Items]            
Change in control percentage   20.00%        
Percent of board members   0.3333        
Term of employment agreement   2 years        
Number of times annual salary   200.00%        
Corporation's Chairman, President and CEO            
Schedule of Shareholders' Equity [Line Items]            
Number of times annual salary   300.00%        
Director plan            
Schedule of Shareholders' Equity [Line Items]            
Available for future issuance (shares) | shares         300,000  
Purchase Plan            
Schedule of Shareholders' Equity [Line Items]            
Available for future issuance (shares) | shares           800,000
Rights to purchase stock, minimum working hours per week | hour   20        
Rights to purchase stock, minimum working months per year   5 months        
Price of repurchased stock as percent of closing price on the exercise date   85.00%        
Maximum amount fair value for purchase of common stock   $ 25,000        
Shares available for future issuance (shares) | shares   593,223        
Interest rate swap            
Schedule of Shareholders' Equity [Line Items]            
Derivative notional amount $ 75,000,000     $ 150,000,000    
Fixed interest rate 1.42%     1.29%    
Proceeds from derivative instrument $ 500,000          
Gain (loss) on derivative $ 500,000          
Accumulated other comprehensive income (loss)   $ 500,000        
Common Stock            
Schedule of Shareholders' Equity [Line Items]            
Remaining authorized repurchase amount   $ 164,700,000